Jump to main content
Jump to site search

Issue 25, 2018
Previous Article Next Article

A scalable on-demand platform to assemble base nanocarriers for combination cancer therapy

Author affiliations

Abstract

Chemophototherapy is an advanced cancer therapeutic that uses photothermal nanocarriers (NCs) responsive to near-infrared (NIR) light. For the past decade, chemophototherapy has been investigated intensively for clinical translation, and continuous-flow production of biofunctional compounds (NCs, drugs, probes, nanocomposites) has received increasing attention for future therapeutics. However, in situ supply of a stimuli-responsive inorganic core and subsequent tight drug loading on the core are challenging tasks in the practical use of on-demand nanomedicines. Thus, in this study, we designed and evaluated both in vitro and in vivo models of an aero–hydro–aero single-pass production system for chemophotothermally active NCs. We prepare tightly-drug-loadable cores (titanium peroxide [yTiO2] nanovesicles [NVs]) using hydrogen flame pyrolysis of vaporized TiCl4 (aero) and successive ultrasonic H2O2 treatment (hydro). The NVs formed were incorporated with graphene oxide (GO), doxorubicin (D), and polyethylene glycol (P) in a spray to form GO-yTiO2@DP NCs (aero). The NVs’ tight DP loading and endothermic effect induced greater, sustained D release and tumor-selective distribution, even for hyperthermic activity. The results showed the route developed may be a stepping stone to scalable, reconfigurable production for on-demand chemophotothermal therapeutics.

Graphical abstract: A scalable on-demand platform to assemble base nanocarriers for combination cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 18 Apr 2018, accepted on 13 Jun 2018 and first published on 14 Jun 2018


Article type: Communication
DOI: 10.1039/C8NR03159B
Citation: Nanoscale, 2018,10, 11737-11744
  •   Request permissions

    A scalable on-demand platform to assemble base nanocarriers for combination cancer therapy

    M. Gautam, S. K. Ku, J. O. Kim and J. H. Byeon, Nanoscale, 2018, 10, 11737
    DOI: 10.1039/C8NR03159B

Search articles by author

Spotlight

Advertisements